Equities

Gabelli Healthcare & WellnessRx Trust

GRX:NYQ

Gabelli Healthcare & WellnessRx Trust

Actions
FinancialsClosed End Investments
  • Price (USD)10.20
  • Today's Change0.150 / 1.49%
  • Shares traded33.69k
  • 1 Year change+3.66%
  • Beta1.0261
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • GRX:NYQ price moved over +1.09% to 10.16

Key statistics

On Wednesday, Gabelli Healthcare & WellnessRx Trust (GRX:NYQ) closed at 10.20, -1.90% below its 52-week high of 10.40, set on Apr 28, 2023.
52-week range
Today
7.73Oct 27 202310.40Apr 28 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open10.10
High10.20
Low10.07
Bid4.08
Offer16.21
Previous close10.20
Average volume31.38k
Shares outstanding15.80m
Free float14.65m
P/E (TTM)23,720.93
Market cap161.16m USD
EPS (TTM)0.0004
USD
Annual div (ADY)0.600
USD
Annual div yield (ADY)5.97%
Div ex-dateMar 13 2024
Div pay-dateMar 21 2024
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
More ▼
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.